Evaluation of the Long Term Efficacy of Endovascular Treatment of Type 2 Endoleaks
NCT ID: NCT04409717
Last Updated: 2020-06-01
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
19 participants
OBSERVATIONAL
2020-01-01
2020-05-26
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Prevention of Type II Endoleaks During Endovascular Treatment of Abdominal Aortic Aneurysm: Endovascular Treatment Versus Combination With Coil Embolisation of the Aneurysmal Sac
NCT01878240
Prevention of Endoleaks Using Autologous Platelet Gel on Unruptured Abdominal Aortic Aneurysms
NCT00372138
Abdominal Compartment Syndrome and Ruptured Aortic Aneurysm : Validation of a Predictive Test
NCT02859662
Secondary Rupture of Aortic Aneurysm Post EVAR
NCT04507334
Analysis of Respiration-induced Deformities of the Visceral and Renal Arteries Before and After Stenting
NCT04724863
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
RETROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Patients treated for type II endoleaks
Patients treated for type II endoleaks between the 01 January 2008 and the 31 March 2018 in the Cardiovascular and Thoracic Surgery Unit of Dijon Burgundy University Hospital
Type II endoleak treatment
Type II endoleak endovascular treatment
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Type II endoleak treatment
Type II endoleak endovascular treatment
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
18 Years
99 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Centre Hospitalier Universitaire Dijon
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Eric STEINMETZ
Professor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Eric STEINMETZ, MD
Role: PRINCIPAL_INVESTIGATOR
Cardiovascular and Thoracic Surgery Unit - Dijon Univeristy Hospital
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Cardiovascular and thoracic surgery unit, CHU Dijon
Dijon, , France
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
CCVT - type 2 endoleaks
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.